Injectables

Home / Resources / Fact Sheets Fact Sheet Anti-psoriasis efficacy testing for topical & injectable drugsExplore InflammaSkin® for anti-psoriatic therapy testing InflammaSkin® is a T cell–driven human skin inflammation model with a Th17/Th1 phenotype, designed to support the evaluation of anti-psoriatic therapies in a human-relevant context. The model can be used with topical, intradermal, or systemic-like treatment approaches and supportsRead more

Home / Resources / Posters Poster Improving Clinical Translation Through Human Skin-Based New Approach Methodologies Adeline Chaubet1, Mathias Peries1, Mamoudou Diallo1, Laurianne Kandalaft1, Anthony David1, Emeline Pagès1, Nicolas Gaudenzio1,2 1Genoskin SAS, Toulouse, France & 2University of Toulouse, Inserm, CNRS, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse, France. Advancing drug development with New Approach Methodologies (NAMs) Predicting human immuneRead more

Home / Resources / Posters Poster A drug development platform for immunogenicity and toxicity assessment using advanced multi-omic profiling Manon Scholaert1,2, Mathias Peries2, Emilie Braun2, Alexandra Ochando3, Emeline Pagès2 and Nicolas Gaudenzio1,2 1Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, France, 2Genoskin SAS, Toulouse, France, 3Genoskin Inc, Salem MA, USA LongitudinalRead more

Home / Resources / Events Conferences Genoskin at the EUROTOX 2026 Congress Advancing drug development with New Approach Methodologies (NAMs) Genoskin was pleased to exhibit in the EUROTOX 2026 Congress from September 13th to 16th at the Austria Center Vienna (ACV), Vienna (Austria). Organised by the Austrian Society of Toxicology, EUROTOX was celebrating its 60th Congress in Vienna and embracedRead more

Home / Resources / Posters Poster Replacing animal testing in local tolerance assessment of an injection device: Human ex vivo HypoSkin® model as a New Approach Methodology (NAM) Jérémy Argenty1, Clémence Letzelter1, Catherine Marques1, Sophie Abadie1, Alexia Sanchez1, Claire Gendrin1, Alexandra Ochando1, Adam Rock2, Ronan Byrne2, Pascal Descargues1 and Nicky Bertollo2 1Genoskin, 2Pharma Latch Advancing intradermal device safety testing withRead more

Home / Resources / Posters Poster HypoSkin® as a human-based NAMs platform for local toxicity and formulation safety assessment Julie Magerman1, Katarzyna Polak2, Ornella Binazon1, Michael Pastore2, Alexandra Ochando2 and Judith Baumeister1 1argenx, 2Genoskin Local Toxicity and Formulation Safety: An argenx Collaboration Study Evaluating the local safety of injectable formulations remains challenging, as conventional preclinical methods may not fully predictRead more